| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,990 |
3,113 |
$174K |
| 87428 |
|
282 |
274 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
287 |
182 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
966 |
609 |
$14K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
888 |
652 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,875 |
593 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,589 |
1,172 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,143 |
1,536 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
194 |
144 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
78 |
73 |
$1K |
| 87807 |
|
258 |
121 |
$625.99 |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
74 |
45 |
$492.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,304 |
972 |
$359.09 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
128 |
77 |
$290.38 |
| 81001 |
|
229 |
151 |
$273.18 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
487 |
333 |
$239.12 |
| 81025 |
|
104 |
45 |
$186.77 |
| 82947 |
|
64 |
24 |
$38.28 |
| 90715 |
|
36 |
34 |
$0.00 |
| 90651 |
|
12 |
12 |
$0.00 |